As expected, the factors that account for non-initiation of insulins and treatments for cardiovascular disease differ from those identified in the primary study [14], which explored factors that explained non-initiation of treatments for acute and chronic physical and mental disorders. The gene discussed is INS; the disease is psychiatric disorder.